AUSTRALIAN SPORTS ANTI-DOPING AUTHORITY 2013:14 ANNUAL REPORT
TABLE OF CONTENTS
Letter of transmittal 3
About this report 4
Message from the CEO 10
Chapter 1: Organisational overview 17
About ASADA 18
Legislative basis 18
Purpose 19
Role and functions 19
Outcome and programme structure 20
Australia’s anti-doping structure 20
13-14 Achievements and highlights 22
Chapter 2: Report on performance 25
Programme 1.1 — Deterrence, detection and enforcement 26
Deliverables 26
Key performance indicators 28
Building awareness 30
Awareness-raising 30
Digital communications channels 30
Communication campaigns 31
Media 32
Printed resources 33
Searching the status of substances online 33
Telephone support 33
Education 35
Partnerships 36
Engagement 38
Assisting sporting organisations 38
International engagement 38
Detection 41
National testing and sport operations programme 42
Sample collection 42
Pure Performance programmes 42
User-pays tests 43
Long-term storage facility 43
Accreditation of DCOs and Chaperones 44
Intelligence 44
Investigations 45
Australian Federal Police review 45
Disclosure notices 45
Disclosure of protected customs information 46
Federal Court proceedings 46
Athlete whereabouts 46
Enforcement 47
Athlete counselling service 49
Chapter 3: Management and accountability 51
Corporate governance 52
Corporate and operational planning 52
Organisational structure and senior executive arrangements 52
Governance committees 54
Risk management 55
Ethical standards 56
Internal audits 57
Records management 57
Quality management 57
External scrutiny 59
Decisions and reports 59
Management of human resources 60
Workforce planning 60
Attraction and retention 60
Employment agreements 60
Section 24(1) determinations 61
Non-salary benefits 61
Performance pay 61
Australia Day medallion 61
Learning and development 62
Commonwealth Disability Strategy 62
Workplace health and safety 62
Chapter 4: Financial information 65
Summary of financial performance 2013–14 66
Asset management 66
Purchasing 67
Engagement of consultants and contractors 67
Consultants 67
Competitive tendering and contracting 68
Auditor-General access 68
Exempt contracts 68
Grant programmes 68
Chapter 5: Financial statements 71
Chapter 6: ASADA Advisory Group 125
Overview 126
Advisory Group members 126
Resources 127
Chapter 7: Anti‑Doping Rule Violation Panel 129
Overview 130
Functions 130
Members 130
Resources 133
Freedom of information — ADRVP 133
Chapter 8: Australian Sports Drug Medical Advisory Committee 135
Overview 136
Functions 136
Therapeutic approvals for prohibited substances 137
Members 137
Resources 139
Therapeutic Use Exemptions granted 139
Freedom of information — ASDMAC 141
Chapter 9: Appendixes 143
Appendix A: Doping control statistics 2001–02 to 2013–14 144
Appendix B: Publicly announced anti-doping rule violations 2013–14 145
Appendix C: International anti-doping arrangements 148
Appendix D: Powers of the Minister to give directions to the ASADA CEO 149
Appendix E: ASADA and CEO functions, powers and delegations 150
Appendix F: Staffing statistics at 30 June 2014 151
Appendix G: Workplace health and safety 153
Appendix H: Advertising and market research 154
Appendix I: Ecologically sustainable development and environmental performance 155
Appendix J: Expenses for Outcome 1 156
Appendix K: ASADA Resource Statement 2013–14 157
Appendix L: Correction of error in the 2012–13 Annual Report 158
Chapter 10: Abbreviations and glossary 161
List of abbreviations 162
Glossary 163
Chapter 11: Indexes 167
Compliance index 168
Alphabetical index 172
LIST OF FIGURES
Figure 1: Outcome and programme structure 2013–14 20
Figure 2: Australia’s anti-doping framework 21
Figure 3: Number of athletes and support personnel recording anti-doping rule violations 49
Figure 4: Organisational structure at 30 June 2014 53
LIST OF TABLES
Table 1: Programme 1.1 qualitative deliverables 26
Table 2: Programme 1.1 quantitative deliverables 27
Table 3: Programme 1.1 qualitative key performance indicators 28
Table 4: Programme 1.1 quantitative key performance indicators 29
Table 5: Education activities undertaken during 2013–14 36
Table 6: Satisfaction with ASADA education 38
Table 7: Anti-doping tests conducted by ASADA in 2013–14 43
Table 8: Doping control facts and figures 2013–14 44
Table 9: Disclosure Notices 46
Table 10: Substances involved in anti-doping matters 2013–14 48
Table 11: Breakdown of anti-doping rule violations 2013–14 48
Table 12: Expenditure on new and existing consultancy contracts 2013–14 67
Table 13: Trends in Consultancies 68
Table 14: Advisory Group attendance 2013–14 127
Table 15: Advisory Group expenses 2013–14 127
Table 16: ADRVP attendance 2013–14 133
Table 17: ADRVP expenses 2013–14 133
Table 18: ADRVP freedom of information statistics 133
Table 19: ASDMAC members 138
Table 20: ASDMAC expenses 2013–14 139
Table 21: 2013–14 Therapeutic Use Exemptions granted 139
Table 22: Substances and methods approved for therapeutic use 2013–14 141
Table 23: ASDMAC freedom of information statistics 141
Table 24: Doping control statistics 144
Table 25: Publicly announced anti-doping rule violations 145
Table 26: Entries on Register of Findings 2012–13 where the outcomes were to be advised 146
Table 27: Entries on Register of Findings 2011–12 where the outcomes were to be advised 147
Table 28: Government-to-government arrangements 148
Table 29: Full-time, part-time and casual staff at 30 June 2014 151
Table 30: Ongoing, non-ongoing and casual staff by classification groups and location at 30 June 2014 151
Table 31: SES staff at 30 June 2014 151
Table 32: Salary ranges of employees 152
Table 33: Number of staff in the collective agreement or section 24(1) determinations 152
Table 34: Advertising and market research 154
Table 35: Expenses for Outcome 1 156
Table 36: ASADA Resource Statement 2013–14 157
